Lychee (Litchi chinensis) is an important tropical fruit crop with rich genetic diversity and significant economic value. To support lychee research, breeding, and germplasm resource management, 3CR Bioscience provides advanced ready-to-use GBTS marker panels enabling high-throughput, cost-effective, and reliable genotyping.
For projects with specific genotyping requirements, custom GBTS panels can also be developed. Contact us to discuss a solution tailored to your breeding program.
Available panels
Documentation
Product Highlights
Our panels provide comprehensive coverage of genetic variation across diverse lychee germplasm resources, supporting accurate genetic characterisation, diversity analysis, and breeding applications.
Our ready-to-use GBTS panels are available in multiple marker densities, from low to high, providing flexible solutions to optimise cost, throughput, and research requirements. We also offer marker number adjustment and panel upgrade services to ensure your research remains at the forefront.
The GenoBaits® Litchi 40K Panel was developed using high-depth resequencing data from 875 lychee samples, including 825 publicly available resources and 50 newly sequenced accessions covering diverse geographic regions. This panel provides a cost-effective, flexible, and versatile solution for genetic analysis and digitalisation of lychee germplasm resources.
Applications
Discovery service
Submit your details and request more information about the panel you’re interest in. Whether it’s for an existing panel listed here or a new inquiry, please complete the form below, and we will respond promptly with further information.
"(Required)" indicates required fields
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.
During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.
Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
You are currently viewing a placeholder content from Brevo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
